XBiotech Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the annual meeting of stockholders held on June 22, 2022. XBiotech Inc., incorporated in British Columbia, Canada, reported the results of shareholder votes on director elections and auditor ratification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted in accordance with the Board of Directors' recommendations on all matters.
Proposal #1: Election of Directors
Five nominees were elected to the Board of Directors. Vote totals were as follows:
| Director Nominee | For | Against | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| John Simard | 10,345,079 | 154,051.50 | 1,766,205 | N/A |
| Jan-Paul Waldin | 7,064,338 | 3,434,792.50 | 1,766,205 | N/A |
| W. Thorpe McKenzie | 9,063,910 | 1,435,220.50 | 1,766,205 | N/A |
| Donald MacAdam | 10,012,289 | 486,841.50 | 1,766,205 | N/A |
| Peter Libby | 10,349,049 | 150,081.50 | 1,766,205 | N/A |
Proposal #2: Auditor Ratification
Shareholders ratified the selection of Whitley Penn LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
- For: 12,037,583.29
- Against: 77,288.21
- Abstain: 150,464.00
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the full composition of the newly elected Board of Directors.
- Confirm the engagement terms and scope of Whitley Penn LLP for the 2022 fiscal year.
- Note the significant number of abstentions and broker non-votes recorded for the director elections.
- Review the company's most recent 10-K or 10-Q for financial performance data not included in this 8-K.